Additionally, the absence of anti-nuclear antibodies (ANA), negative scleroderma-associated antibodies (Scl-70), negative antiphospholipid and cardiolipin antibodies, and normal complement C4 levels effectively excluded other systemic autoimmune and complement-mediated inflammatory diseases. The gene discussed is BTG3; the disease is scleroderma.